S&P 500   5,094.45 (+0.11%)
DOW   39,175.86 (+0.11%)
QQQ   437.36 (+0.13%)
AAPL   182.39 (-0.07%)
MSFT   411.10 (+0.19%)
META   483.65 (-0.08%)
GOOGL   142.62 (-0.93%)
AMZN   176.19 (+0.69%)
TSLA   192.64 (+0.35%)
NVDA   796.99 (+1.12%)
NIO   5.53 (+2.41%)
AMD   177.88 (+0.77%)
BABA   75.85 (-0.14%)
T   16.78 (-0.12%)
F   12.14 (+0.00%)
MU   89.89 (+4.52%)
CGC   3.36 (+0.00%)
GE   153.57 (+0.16%)
DIS   107.67 (-0.06%)
AMC   4.48 (+0.90%)
PFE   27.69 (-0.25%)
PYPL   59.09 (-0.12%)
XOM   103.80 (-0.04%)
S&P 500   5,094.45 (+0.11%)
DOW   39,175.86 (+0.11%)
QQQ   437.36 (+0.13%)
AAPL   182.39 (-0.07%)
MSFT   411.10 (+0.19%)
META   483.65 (-0.08%)
GOOGL   142.62 (-0.93%)
AMZN   176.19 (+0.69%)
TSLA   192.64 (+0.35%)
NVDA   796.99 (+1.12%)
NIO   5.53 (+2.41%)
AMD   177.88 (+0.77%)
BABA   75.85 (-0.14%)
T   16.78 (-0.12%)
F   12.14 (+0.00%)
MU   89.89 (+4.52%)
CGC   3.36 (+0.00%)
GE   153.57 (+0.16%)
DIS   107.67 (-0.06%)
AMC   4.48 (+0.90%)
PFE   27.69 (-0.25%)
PYPL   59.09 (-0.12%)
XOM   103.80 (-0.04%)
S&P 500   5,094.45 (+0.11%)
DOW   39,175.86 (+0.11%)
QQQ   437.36 (+0.13%)
AAPL   182.39 (-0.07%)
MSFT   411.10 (+0.19%)
META   483.65 (-0.08%)
GOOGL   142.62 (-0.93%)
AMZN   176.19 (+0.69%)
TSLA   192.64 (+0.35%)
NVDA   796.99 (+1.12%)
NIO   5.53 (+2.41%)
AMD   177.88 (+0.77%)
BABA   75.85 (-0.14%)
T   16.78 (-0.12%)
F   12.14 (+0.00%)
MU   89.89 (+4.52%)
CGC   3.36 (+0.00%)
GE   153.57 (+0.16%)
DIS   107.67 (-0.06%)
AMC   4.48 (+0.90%)
PFE   27.69 (-0.25%)
PYPL   59.09 (-0.12%)
XOM   103.80 (-0.04%)
S&P 500   5,094.45 (+0.11%)
DOW   39,175.86 (+0.11%)
QQQ   437.36 (+0.13%)
AAPL   182.39 (-0.07%)
MSFT   411.10 (+0.19%)
META   483.65 (-0.08%)
GOOGL   142.62 (-0.93%)
AMZN   176.19 (+0.69%)
TSLA   192.64 (+0.35%)
NVDA   796.99 (+1.12%)
NIO   5.53 (+2.41%)
AMD   177.88 (+0.77%)
BABA   75.85 (-0.14%)
T   16.78 (-0.12%)
F   12.14 (+0.00%)
MU   89.89 (+4.52%)
CGC   3.36 (+0.00%)
GE   153.57 (+0.16%)
DIS   107.67 (-0.06%)
AMC   4.48 (+0.90%)
PFE   27.69 (-0.25%)
PYPL   59.09 (-0.12%)
XOM   103.80 (-0.04%)
OTCMKTS:TSMRF

Tsumura & Co. (TSMRF) Stock Price, News & Analysis

$18.86
0.00 (0.00%)
(As of 02/23/2024 ET)
Today's Range
$18.86
$18.86
50-Day Range
$18.10
$18.86
52-Week Range
$18.75
$18.86
Volume
N/A
Average Volume
100 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

TSMRF stock logo

About Tsumura & Co. Stock (OTCMKTS:TSMRF)

Tsumura & Co. manufactures and sells pharmaceutical products worldwide. The company offers Kampo extract intermediates and granular Kampo formulations. It is involved in the procurement, selection and processing, and storage of raw material crude drugs and crude drug pieces for decoction; manufacture of Kampo powdered extracts and traditional Chinese medicines; and sale of pharmaceuticals and food products. The company was founded in 1893 and is headquartered in Tokyo, Japan.

TSMRF Stock Price History

TSMRF Stock News Headlines

Tsumura & Co. (4540.T)
Blue Chips And Billionaires Quietly Investing In "The New Oil"
They're as essential to the tech and AI revolutions as oil was to the industrial revolution. Known as rare earth elements or REEs, these relatively unheard of commodities are essential to semiconductor chips, renewable energy, electric vehicles, and more.
Boulder, CO
See More Headlines
Receive TSMRF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tsumura & Co. and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
OTCMKTS:TSMRF
CIK
N/A
Fax
N/A
Employees
4,032
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Terukazu Kato (Age 61)
    President, CEO & Representative Director
    Comp: $837.27k
  • Mr. Muneki Handa (Age 62)
    CFO & Director
  • Mr. Koin Toda
    Co-Chief Operating Officer
  • Mr. Kei Sugii (Age 55)
    Co-COO & Director
  • Hiroshi Hoshi
    GM of Legal & Compliance Control and Executive Officer
  • Makoto Kitamura
    Head of Corporate Communications Dept.
  • Yukinori Sorata
    Exec Officer, GM of Prescription Pharmaceutical Sales Div and Head of Sales & Marketing Division
  • Mr. Susumu Adachi (Age 61)
    Chief Human Resources Officer
  • Mr. Kimitoshi Usui
    Head of Production Division
  • Mr. Ryouichi Murata
    Manager of Tsumura Academy & Executive Officer














TSMRF Stock Analysis - Frequently Asked Questions

Should I buy or sell Tsumura & Co. stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Tsumura & Co. in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" TSMRF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TSMRF, but not buy additional shares or sell existing shares.
View TSMRF analyst ratings
or view top-rated stocks.

How have TSMRF shares performed in 2024?

Tsumura & Co.'s stock was trading at $18.10 at the start of the year. Since then, TSMRF stock has increased by 4.2% and is now trading at $18.86.
View the best growth stocks for 2024 here
.

Are investors shorting Tsumura & Co.?

Tsumura & Co. saw a drop in short interest during the month of January. As of January 15th, there was short interest totaling 5,600 shares, a drop of 21.1% from the December 31st total of 7,100 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is presently ∞ days.
View Tsumura & Co.'s Short Interest
.

How do I buy shares of Tsumura & Co.?

Shares of TSMRF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:TSMRF) was last updated on 2/26/2024 by MarketBeat.com Staff